Pilates Mat Exercises for Movement and Fitness in Middle-Aged Women With Obesity
Tests a 12-week Pilates mat exercise program in women aged 45 to 55 with obesity.
Plain-language title generated from the registry record
Registry title: Pilates Mat Exercises Training on Functional Performance in Middle Age Obese Women
Key facts
- Where
- Cairo, EgyptSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 45 and 55 years old?
Source: NCT06779383, who can take part
Where in Egypt
- Mona Mohamed AbdelkhalekCairo, EgyptNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Badr University
- Trial code
- NCT06779383
- Record updated
- 16 January 2025
- Original description
• Aim of the study: This study will aim to investigate the effects of a 12-week Pilates-mat exercise program on the functional performance in middle age obese women.Read full original descriptionShow less
Effect of Pilates Mat Exercises Training on Functional Performance in Middle Age Obese Women: Randomized Controlled Trial
• Aim of the study: This study will aim to investigate the effects of a 12-week Pilates-mat exercise program on the functional performance in middle age obese women.
Materials and Methods:
sixty obese women patients (ages 45-55 years old) with a body mass index (BMI) 30 -34.9 kg/m2.Women will be randomly assigned into experimental group(Pilates) or control group, (3 times/week, 60 min/session) their age from 45 to 55 yrs. The Pilates exercises were performed on mats. The functional performance on one-leg stance (OLS), five-times-sit-to-stand (STS) and 6-min walk (6 MW) tests was evaluated before and after the 12-week Pilates training or control follow-up period.
Inclusion: women; BMI between 30 to 34.9 kg/m2; Age will range from 45-55 years old; Exclusion criteria.
Exclusion: Cardiac diseases; Liver diseases; Hypertension; Musculoskeletal disease.